It has been suggested that heptaminol and methylheptaminol should be used as myocardial stimulants because they have cardiotonic actions similar to those of cardiac glycosides. However, as these aliphatic amines show definite sympathomimetic effects, the mechanism of their actions on the heart was investigated, in order to determine whether digitalis-like properties are involved in these effects. The pattern of pharmacological actions of heptaminol and methylheptaminol was compared with that of catechol amines, tyramine and k-strophanthin. The influence of atropine, hexamethonium, cocaine and reserpine was also investigated. The results show that both heptanolamines have a long-lasting cardiostimulant action which is abolished by cocaine and absent in reserpine pretreated animals. The pharmacological activity of these drugs may be entirely attributed to an indirect sympathomimetic action of the tyramine type, probably due to release of endogenous catechol amines. None of the experimental findings is consistent with the alleged digitalis-like action of these compounds.Among the aliphatic amines, the heptylamines with an alcoholic function on carbon two have been the object of a more detailed pharmacological study, as they show cardiostimulating properties which are particularly intense and long-lasting. The two most active compounds of the series, heptaminol (6-amino-2-methyl-2-heptanol; 2831 RP; Heptamyl; Cortensor) and methylheptaminol (6-methylamino-2-methyl-2-heptanol; 3738 RP; Aranthol), have been employed in the therapy of various clinical conditions including heart failure. Their use in heart failure is based on the experimental work of Loubatieres (1949aLoubatieres ( & b, 1951 and Loubatieres, Bouyard, Macabies & Mouralis (1949), who observed digitalis-like cardiotonic effects on the cat papillary muscle preparation fatigued by repeated electrical stimulation and on the dog ventricle ii situ. Coraboeuf & Boistel (1953), recording the action potentials of cardiac tissue by means of intracellular microelectrodes, concluded that heptaminol shows powerful cardiotonic effects.These heptanolamines, however, exhibit pharmacological actions which may be interpreted as depending on an activation of sympathetic receptors (Jackson, 1947;Walton, Belkin & Brodie, 1947;Huggins, Handley & La Forge, 1949;Marsh & Herring, 1951; Garrett, 1954; v. Haxthausen, 1955;Hille & Teske, 1957). It thus seems necessary to characterize the nature of their cardiostimulating action, in order to ascertain whether, as well as their sympathomimetic action, there is also a digitalis-like component which may significantly contribute to the cardiac effects.